EU Cites ‘Constructive’ Talks With Gilead Over Virus Drug

Published July 6, 2020

European Union officials held talks with Gilead Sciences Inc. executives on Monday in a bid to hammer out a deal to secure its antiviral drug remdesivir to combat the coronavirus.

Related Stories